Wagner, L., Abonour, R., Ailawadhi, S., Durie, B. G. M., Gasparetto, C. J., Hardin, J. W., … Jagannath, S. (2021). Health-related quality of life (HRQL) among real-world Ide-Cel-eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 21, pp. S109–S109).

Wagner, Lynne, Rafat Abonour, Sikander Ailawadhi, Brian G. M. Durie, Cristina J. Gasparetto, James W. Hardin, Hans Lee, et al. “Health-related quality of life (HRQL) among real-world Ide-Cel-eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 21:S109–S109, 2021.

Wagner L, Abonour R, Ailawadhi S, Durie BGM, Gasparetto CJ, Hardin JW, et al. Health-related quality of life (HRQL) among real-world Ide-Cel-eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. p. S109–S109.

Wagner, Lynne, et al. “Health-related quality of life (HRQL) among real-world Ide-Cel-eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 21, 2021, pp. S109–S109.

Wagner L, Abonour R, Ailawadhi S, Durie BGM, Gasparetto CJ, Hardin JW, Lee H, Narang M, Rifkin R, Terebelo H, Toomey K, Joshi P, Agarwal A, Braverman J, Dhanda DS, He M, Jagannath S. Health-related quality of life (HRQL) among real-world Ide-Cel-eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. p. S109–S109.